Indication · Cardiology
Aortic aneurysm and dissection
Last checked: Nov 19, 2026Source: FDA, ClinicalTrials.gov
Devices
147
Cleared or approved since 2000
PMA and De Novo
69
Higher-risk or first-of-kind devices
Breakthrough devices
4
Authorized through June 30, 2026
Recruiting device trials
90
416 device trials in all
Breakthrough-designated devices
- NEXUS Aortic Arch Stent Graft SystemEndospan , Ltd. · 2026
- Thoraflex HybridVascutek, Ltd. · 2026
- GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1W. L. Gore & Associates, Inc. · 2026
1 more devices with a free account
Devices
147 devices. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1
W. L. Gore & Associates, Inc. · PMA · System, Endovascular Graft, Aortic Aneurysm Treatment · newest 2026 · 17 decisions
- Ancure Endograft System
Boston Scientific Corp · PMA · System, Endovascular Graft, Aortic Aneurysm Treatment · newest 2003 · 15 decisions
- Aneurx Stent Graft System
Medtronic Vascular · PMA · System, Endovascular Graft, Aortic Aneurysm Treatment · newest 2011 · 11 decisions
57 more devices with a free account
Showing the first 60. Narrow by pathway, or open a device type below.
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
- Post-Approval Study of the TREO Abdominal Stent-Graft SystemActive, not recruiting
Bolton MedicalNot on our public-company list
NCT04697784 · 338 participants · Start Jan 20, 2021 · Primary completion Oct 31, 2028
Device: TREO Abdominal Stent-Graft System · For: Abdominal Aortic Aneurysm
Sites: Phoenix, Arizona; Tucson, Arizona; Fresno, California · 40 sites in all
- Quick Yielding Modified Short-Distance Fenestration Technique for the Treatment of Complex Aortic Arch Diseases: A Multicenter Single-Arm Objective Performance Criteria Trial(QYM-Tech Study)Active, not recruiting
Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineAcademic, hospital or other
NCT06639243 · 87 participants (planned) · Start Jan 1, 2024 · Primary completion Dec 31, 2028
Device: QYM Technique · For: Thoracic Aortic Dissection; Thoracic Aortic Aneurysm (True Aneurysm); Thoracic Pseudoaneurysm and 2 more
Sites: Shanghai, China
Bolton MedicalNot on our public-company list
NCT02009644 · 158 participants · Start Nov 23, 2013 · Primary completion Mar 20, 2017
Device: Subjects who receive the Treovance stent-graft · For: Abdominal Aortic Aneurysm (AAA)
Sites: Birmingham, Alabama; Phoenix, Arizona; Danbury, Connecticut · 29 sites in all
413 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
- System, Endovascular Graft, Aortic Aneurysm Treatment (MIH)60
- Prosthesis, Vascular Graft, Of 6mm And Greater Diameter (DSY)59
- Endovascular Suturing System (OTD)6
- Sensor, Pressure, Aneurysm, Implantable (NQH)5
- Graft, Vascular, Synthetic/Biologic Composite (MAL)4
- Software For Visualization Of Vascular Anatomy And Intravascular Devices (PZO)4
- Aortic Annuloplasty Ring (PST)2
- Hybrid Stent Graft, Thoracic Aortic Lesion Treatment (QSK)2
- Endovascular System For Treatment Of Ascending Aorta And Aortic Arch Lesions (SDZ)2
- Glue, Surgical, Arteries (MUQ)1
- Endovascular System For Treatment Of Thoracoabdominal And Pararenal Aortic Lesions (QZK)1
- Device For Open Surgical Explant Of Endovascular Prostheses (SHR)1
Research
- Device studies on aortic aneurysm across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.